About Cytecare
Cytecare is a company based in Bengaluru (India) founded in 2014 by Suresh Ramu, Himanshu Shah, Ferzaan Engineer, and Anthony Pais was acquired by Omega Hospitals in November 2025. Cytecare has raised $78.45 million across 6 funding rounds from investors including Goldman Sachs, Omega Hospitals and Cytespace Research. The company has 256 employees as of August 19, 2025. Cytecare operates in a competitive market with competitors including HCG, Omega Hospitals, CION Cancer Clinics, American Oncology Institute and Mahatma Gandhi Cancer Hospital, among others.
- Headquarter Bengaluru, India
- Employees 256 as on 19 Aug, 2025
- Founders Suresh Ramu, Himanshu Shah, Ferzaan Engineer, Anthony Pais
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cytecare Hospitals Private Limited
- Date of Incorporation 11 Mar, 2014
- Jurisdiction Ahmedabad, Gujarat, India
-
Annual Revenue
$10.88 M (USD)18.72as on Mar 31, 2024
-
Net Profit
-$1.76 M (USD)60.15as on Mar 31, 2024
-
EBITDA
-$13.07 K (USD)98.54as on Mar 31, 2024
-
Total Equity Funding
$78.45 M (USD)
in 6 rounds
-
Latest Funding Round
$1.89 M (USD), Series B
Jul 20, 2022
-
Investors
Goldman Sachs
& 42 more
-
Employee Count
256
as on Aug 19, 2025
-
Acquired by
Omega Hospitals
(Nov 05, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Cytecare
Unlock access to complete
Unlock access to complete
Funding Insights of Cytecare
Cytecare has successfully raised a total of $78.45M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $1.89 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cytecare
Cytecare has secured backing from 43 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Goldman Sachs, Omega Hospitals and Cytespace Research.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment banking services are delivered across multiple financial sectors.
|
Locked | Locked | Locked | |
|
Venture capital is provided to tech startups by the fund.
|
Locked | Locked | Locked | |
|
Seed-stage investments are targeted by Jacesa Investments venture capital firm.
|
Locked | Locked | Locked |
Investor details for Cytecare
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cytecare
Investment portfolio details for Cytecare
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cytecare
Detailed financials for Cytecare
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cytecare Comparisons
Peer comparison for Cytecare
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cytecare
Cytecare operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as HCG, Omega Hospitals, CION Cancer Clinics, American Oncology Institute and Mahatma Gandhi Cancer Hospital, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Chain of oncology hospitals
|
|
| Locked | Locked | Locked |
Specialized oncology treatments are offered by a hospital chain.
|
|
| Locked | Locked | Locked |
Cancer treatments and support are provided by a clinic chain.
|
|
| Locked | Locked | Locked |
Cancer care is provided through a chain of specialized hospitals.
|
|
| Locked | Locked | Locked |
Cancer care is delivered via a chain of accredited hospitals.
|
Detailed competitors of Cytecare
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cytecare
Complete news archive for Cytecare
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cytecare
Cytecare was founded in 2014.
Cytecare is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Suresh Ramu is the current CEO of Cytecare. They have also founded this company.
Cytecare is a funded company, having raised a total of $78.45M across 6 funding rounds to date.
As of Aug 19, 2025, the latest employee count at Cytecare is 256.
Annual revenue of Cytecare is $10.88M as on Mar 31, 2024.
Chain of oncology hospitals. It specializes in a wide range of cancer treatments, including advanced surgical care, Pediatric, Interventional, Uro Neuro oncology, Bone Marrow transplant, Gastrointestinal Cancer Treatment, Pain and Palliative Care, chemotherapy, ENT care, radiotherapy, Organ-Site Focused Care, Holistic Patient Support, Advanced Diagnostic Services, and more.
Cytecare's top competitors include HCG, CION Cancer Clinics and Omega Hospitals.
Cytecare has 43 investors. Key investors include Goldman Sachs, Omega Hospitals, Cytespace Research, Shanghvi Finance, and Synergy AG.
The valuation of Cytecare is $34.1M as of Jul 2022.